The next frontier of precision medicine, the global precision cardiology market showcases enormous potential to completely revolutionize the field of cardiovascular disease diagnosis, which is further anticipated to help stakeholders reduce the burden associated with these conditions. Significant strides in advancing sequencing technologies tools have facilitated an increasing number of cardiovascular genetic studies to be performed in the field of cardiology. Moreover, these studies have provided key insights into the underlying micro-environment, which is further harnessed by researchers, physicians, and market players to develop novel solutions for detecting cardiovascular conditions. To address this critical requirement, biotechnology companies are significantly investing in research and development (RD) to expand their respective precision cardiology portfolios for clinical and research applications. Our healthcare experts have found the precision cardiology marke...